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among noncolonized children. The 
OR among the enrolled case-patients 
(ORcase-patient) becomes rn/rc, which is 
the reciprocal of the risk ratio (RR) 
of developing the disease (RR = rc/rn) 
(online Technical Appendix). Usually, 
RR is >1 for diseased children and 
<1 for healthy children. Therefore, 
even in this independent coloniza-
tion scenario, ORcase-patient becomes <1 
(“pseudo-competitive associations”) 
in diseased children, and ORcase-patient 
becomes >1 (“pseudo-synergistic as-
sociations”) in healthy children. This 
is probably what the authors have ob-
served in the study.
We cannot infer an association 
of multiple bacterial colonizations in 
a population despite an observed as-
sociation in the diseased (or healthy) 
children, and this association is wide-
ly misunderstood (2–4). The authors’ 
discussion regarding a potential 
emergence of H. influenzae, associ-
ated with AOM, after the introduction 
of pneumococcal conjugate vaccine 
is thus unjustifiable.
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In Response: The point made 
by Suzuki et al. (1) is an interesting 
one, but it is not directly relevant to 
our conclusions (2). To summarize, 
given bacterium 1 and bacterium 
2, suppose OR[pop] is the odds ra-
tio (OR) between bacterium 1 and 
bacterium 2 in the population. If r[c] 
and r[n] are the risk of enrollment 
among colonization-positive and col-
onization-negative children, respec-
tively, then OR[case] = (r[n]/r[c])
OR[pop], so that OR[case] <1 can 
be attributed to a higher risk among 
colonized children.
The underlying assumption of 
the analysis is that enrollment risk 
is constant for both bacteria (alone 
or in combination). In fact, differen-
tial risk does exist, and it cannot be 
separated from the issue of the rela-
tive aggressiveness of the bacterium. 
This can be seen by considering the 
ORs in the Table.
When we compared the ORs 
between bacteria pairs for all sub-
jects and children with acute otitis 
media (AOM), we found a large de-
crease for pairs involving nontypeable 
Haemophilus influenzae (NTHi), in 
contrast to the remaining pair, Strep-
tococcus pneumoniae/ Moraxella ca-
tarrhailis (Spn/Mcat). We do not be-
lieve that these values are explainable 
by the effect described by Suzuki et 
al., especially when (as is done in that 
analysis) we assume a colonization-
positive risk of enrollment r[c] that is 
independent of bacterium distribution. 
We also point out that these estimates 
are instructive, but not sufficient, be-
cause each pairwise comparison may 
depend on interactions with the third 
bacterium. We therefore used a statis-
tical model (2,3) that permits the isola-
tion of third-order effects by modeling 
co-occurrence rates of 2 bacteria while 
controlling for a third. This allowed us 
to reach our conclusion, which is pri-
marily concerned with the specific role 
played by NTHi, and follows from the 
existence of a pattern in the reported 
ORs, rather than the absolute value of 
any single OR.
It is also instructive to examine 
the colonization rates for AOM versus 
number of AOM events (nAOM) sub-
jects: p(Spn-nAOM) = 0.30; p(Spn-
AOM) = 0.53; p(NTHi-nAOM) = 
0.12; p(NTHi-AOM) = 0.48; p(Mcat 
-nAOM) = 0.36; p(Mcat-AOM) = 
0.43. As we would expect, coloni-
zation rates of each bacterium are 
higher for AOM patients. What is of 
interest is that the colonization distri-
bution is different for children with 
AOM, which suggests that NTHi is 
more aggressive than other bacteria 
in some sense, and this effect is made 
more precise by the statistical model 
we used. The essential point is that 
the issue of competitive association 
cannot be isolated from differential 








NTHi/Mcat 0.94,	p	=	0.6935 0.47,	p	=	0.0006 
NTHi/Spn 1.58,	p	=	0.0004 0.50,	p	=	0.001 
Spn/Mcat 1.71,	p<0.0001 1.53,	p	=	0.05 









  1. Suzuki M, Dhoubhadel BG, Yoshida 
LM, Ariyoshi K. Nasopharyngeal bac-
terial interactions in children. Emerg 
Infect Dis [Internet]. 2014;20:323–4. 
http://dx.doi.org/10.3201/eid2014.121724
  2. Xu Q, Almudervar A, Casey JR, Pi-
chichero ME. Nasopharyngeal bacte-
rial interactions in children. Emerg Infect 
Dis. 2012;18:1738–45 . http://dx.doi.
org/10.3201/eid1811.111904
  3. Pettigrew MM, Gent JF, Revai K, Patel 
JA, Chonmaitree T. Microbial interactions 
during upper respiratory tract infections. 
Emerg Infect Dis. 2008;14:1584–91. 
http://dx.doi.org/10.3201/eid1410.080119
Address for correspondence: Michael 
Pichichero, Rochester General Hospital 
Research Institute, 1425 Portland Ave, 






To the Editor: In India, 
buffalopox virus (BPXV), a variant 
of vaccinia virus, is associated 
with severe disease outbreaks 
among buffaloes (1,2), cattle (3), 
and humans in contact with these 
animals (1,4). Most human BPXV 
infections occur in animal attendants 
and milkers (1,4). A similar type 
of vaccinia virus infection has also 
been reported from rural areas 
in Brazil (5). We report a case of 
laboratory-acquired infection with 
BPXV in a researcher in India. 
Clinical signs, symptoms, diagnosis, 
and management of this case 
highlight the need for observance 
and enforcement of strict biosafety 
measures within the laboratory.
A 28-year-old man (researcher) 
who was freeze-drying BPXV isolates 
in a laboratory in Hisar, India sustained 
a cut on his right palm through nitrile 
gloves by accidental piercing of 
shrapnel from a broken ampule. The 
virus being freeze-dried (105.5 50% 
tissue culture infectious doses/mL) was 
isolated from a buffalo in Jalgaon, India, 
in 2010. The injured site on the palm 
was immediately cleaned with 70% 
ethanol and treated with povidone–
iodine solution. No untoward reaction 
was observed <2 days postinjury. 
Erythema appeared at the injury site 
on postinjury day 3. Subsequently, a 
small vesicle developed on postinjury 
day 5 (Figure, panel A). This vesicle 
progressed into a pustule with a central 
area of necrosis by postinjury day 7 
(Figure, panel B). On postinjury day 
9, symptoms worsened (onset of high 
fever and general malaise and pain at 
the affected site), and the researcher 
sought medical care.
Physical examination showed 
high fever (104°F), unilateral axillary 
lymphadenopathy, and edema of the 
palm (Figure, panel C). Amoxicillin (500 
mg, 2×/d), cephalexin (500 mg, 2×/d), 
and analgesic/antipyretic (paracetamol, 
500 mg, 2×/d) were prescribed to 
control secondary complications caused 
by bacterial infection and pain.
The next day, the entire palm 
became cyanotic and edema increased 
(Figure, panel D). The researcher was 
then referred to a specialty hospital 
where the lesion was surgically excised 
on postinjury day 11 (Figure, panel E) 
under axial block anesthesia. Blood, 
necrotic tissue, pustular material, and 
swab specimens were obtained for 
laboratory examination. Postsurgery 
treatment included cleaning of the 
surgical site on alternate days and 
oral medication (amoxicillin/clavulanic 
acid, 625 mg; ibuprofen, 400 mg; 
paracetamol, 325 mg; and rabeprazole, 
20 mg) for 5 days.
On postinjury day 19, the surgeon 
advised the patient to take cefuroxime 
(500 mg/d for 5 days) and use a topical 
ointment containing mupirocin to 
prevent a delay in healing (Figure, 
panel F). The lesion healed slowly, and 
by postinjury day 30, thickening and 
blackening of the skin was observed 
(Figure, panel G) that extended to 
a wider area by postinjury day 38, 
and the skin started to peel off by 
postinjury day 50. The entire skin of 
the palm sloughed off with complete 
healing by postinjury day 85, leaving 
a 20-mm blackened eschar over the 
area (Figure, panel H).
Clinical samples were subjected 
to laboratory examination. Virus was 
isolated from tissue samples in a Vero 
cell line during the first passage. BPXV 
infection was confirmed by PCR 
amplification of orthopoxvirus-specific 
A type inclusion gene (552 bp) and a 
BPXV-specific C18L gene (368 bp) 
from tissue material and the laboratory-
isolated virus (BPXV/Human/Lab/11), 
according to procedures described by 
Singh et al. (6). Sequences of these 
2 genes were submitted to GenBank 
under accession nos. JN653284.1 and 
JN653278.1, respectively. Phylogenetic 
analysis showed 95%–100% nt 
similarity of the laboratory isolate 
(BPXV/Human/Lab/11) with other 
BPXVs from India (online Technical 
Appendix Figure, wwwnc.cdc.gov/EID/
article/20/2/13-0358-Techapp1.pdf). 
Antibodies against BPXV were detected 
in patient serum samples by using an 
indirect immunoperoxidase test and a 
50% plaque-reduction neutralization 
test according to methods reported by 
Bera et al. (7). Serum of the infected 
patient showed 50% plaque-reduction 
neutralization test titers of 256 and 
512 on postinjury days 11 and 28, 
respectively. These findings confirmed 
BPXV infection because the patient had 
not been vaccinated against smallpox.
Pre-freezing of the glass ampule 
to –80°C caused a hairline crack in 
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